Ferring Pharmaceuticals announced today the U.S. Food and Drug Administration (FDA) approved a state-of-the-art drug product manufacturing hub in Parsippany, NJ, for its intravesical non-replicating ...

Core Laboratories Inc. ("Core", "Core Lab", or the "Company") reported first quarter 2025 revenue of $123,600,000. Core's operating income was $4,400,000, with earnings per diluted share ("EPS") of $0 ...

Incremental process adjustments, but key challenges persist. Our research team assigns Neutral ratings to strategies they’re not confident will outperform a relevant index, or most peers, over a ...

Disciplined Growth Investors Fund earns an Above Average Process Pillar rating. The main contributor to the rating is the fund's impressive long-term risk-adjusted performance. This can be seen in ...